NEW YORK, Jan. 9, 2017 /PRNewswire/ -- As proton pump inhibitor lawsuits involving serious kidney injuries continue to mount in courts throughout the U.S, a new study suggests that long-term use of these and other heartburn medications could place ... TickerTech.com, 1 week ago
2 images for "Zegerid"
Source Before I start, I want to make something clear: Short sellers are investors too. Shorting a stock is not immoral or evil, and it doesn't deserve the abuse it gets from longs. Investors who short stocks do so at significant risk because ...Seeking Alpha, 3 weeks ago
Janssen Sciences Ireland UC Release: Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen
CORK, Ireland , Dec.19, 2016 /PRNewswire/ --Janssen Sciences Ireland UC (Janssen) today announced that two Phase III studies to evaluate the safety and efficacy of switching virologically suppressed patients from a three or four drug (integrase ...BioSpace, 4 weeks ago Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen 4 Traders, 1 month ago GLAXOSMITHKLINE : ViiV Healthcare announces positive results from first phase III studies of two-drug HIV treatment regimen 4 Traders, 1 month ago ViiV Healthcare announces positive results from first phase III studies of two-drug HIV treatment regimen National AIDS Treatment Advocacy Project, 4 weeks ago
20/12/2016 7:00am UK Regulatory (RNS & others) GlaxoSmithKline (LSE:GSK) Intraday Stock Chart Today : Tuesday 20 December 2016 TIDMGSK RNS Number : 2967S GlaxoSmithKline PLC 19 December 2016 ViiV Healthcare announces positive ...ADVFN UK, 4 weeks ago ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen National AIDS Treatment Advocacy Project, 1 month ago GLAXOSMITHKLINE : ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen 4 Traders, 2 months ago ViiV starts PhIII LA injectable treatment regimen Shares Magazine, 2 months ago
Proton pump inhibitors like esomeprazole, lansoprazole or omeprazole are the most popular treatments for heartburn and reflux disease. It is estimated that 15 million Americans spend $10 billion on such drugs annually. The FDA considers these ...Peoples Pharmacy, 1 month ago
Fellow contributor Giovanni DiMauro published a bearish take on Valeant Pharmaceuticals (NYSE: VRX ) with which I strongly disagree. I'll start by going over DiMauro's points (between quotes) where I hold a variant view and summarize my bullish take ...Seeking Alpha, 1 month ago Why I Am Reversing My Position Of Valeant Pharmaceuticals Seeking Alpha, 1 month ago Valeant Pharmaceuticals: Catching A Falling Knife Safely? Seeking Alpha, 2 months ago
on your WebpageAdd Widget >Get your members hooked!